Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GICOR (Grupo de Investigación Clínica en Oncología y Radioterapia) is a prominent Spanish cooperative research group dedicated to the development and coordination of clinical trials in the fields of oncology and radiotherapy. Established in 1998, the organization functions as a non-profit scientific association that brings together radiation oncologists and other specialists to improve cancer treatment protocols. GICOR focuses on multicenter studies that evaluate the efficacy of radiotherapy in combination with systemic therapies, such as chemotherapy and immunotherapy. The group collaborates extensively with the pharmaceutical industry and academic institutions to conduct high-impact research across various cancer types, including prostate, rectal, and breast cancers. By standardizing clinical practices and fostering innovation, GICOR aims to enhance patient outcomes and advance the standard of care in oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo GICOR.